###begin article-title 0
Oct-4 controls cell-cycle progression of embryonic stem cells
###end article-title 0
###begin p 1
###xml 686 687 686 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 689 690 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 908 911 908 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1109 1112 1109 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 15 <span type="species:ncbi:9606">human</span>
Mouse and human ES (embryonic stem) cells display unusual proliferative properties and can produce pluripotent stem cells indefinitely. Both processes might be important for maintaining the 'stemness' of ES cells; however, little is known about how the cell-cycle fate is regulated in ES cells. Oct-4, a master switch of pluripotency, plays an important role in maintaining the pluripotent state of ES cells and may prevent the expression of genes activated during differentiation. Using ZHBTc4 ES cells, we have investigated the effect of Oct-4 on ES cell-cycle control, and we found that Oct-4 down-regulation in ES cells inhibits proliferation by blocking cell-cycle progression in G0/G1. Deletion analysis of the functional domains of Oct-4 indicates that the overall integrity of the Oct-4 functional domains is important for the stimulation of S-phase entry. We also show in the present study that the p21 gene is a target for Oct-4 repression. Furthermore, p21 protein levels were repressed by Oct-4 and were induced by the down-regulation of Oct-4 in ZHBTc4 ES cells. Therefore the down-regulation of p21 by Oct-4 may contribute to the maintenance of ES cell proliferation.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-3</italic>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-3/4</italic>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 754 758 <span type="species:ncbi:10090">mice</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
Mouse and human ES (embryonic stem) cells display unusual proliferative properties, which are achieved by symmetric cell division, while maintaining their pluripotency. These properties can be regulated by transcriptional control in the nucleus through extracellular signals [1]. The oct-4 gene, also referred to as oct-3 and oct-3/4, encodes a nuclear protein that belongs to a family of transcription factors containing the POU DNA-binding domain [2-7]. Oct-4 is normally expressed in the pluripotent stem cells of pregastrulation embryos, including oocytes, early-cleavage-stage embryos and the ICM (inner cell mass) of the blastocyst [3,4,8,9]. Its expression is down-regulated during differentiation, and knockout of oct-4 causes early lethality in mice due to the absence of an ICM [10]. These results suggest that Oct-4 plays a pivotal role in mammalian development [11] and in the self-renewal of ES cells [12]. During human development, Oct-4 is expressed at least until the blastocyst stage in which it regulates gene expression [13].
###end p 3
###begin p 4
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
Transcriptional regulation by Oct-4 is complex. In ES cells, the octamer sequence motif (5'-ATGCAAAT-3') is active irrespective of its distance from the site of transcriptional initiation [2,14]. However, in differentiated cells, Oct-4 can transactivate its targets only when the octamer motif is in a proximal position [3,15,16]. If the octamer motif is at a distal site, the protein requires stem-cell-specific bridging factors that link it to the transcription initiation site [15]. A number of factors such as Sox2, HMG (high-mobility group), E7, E1A and EWS are known to influence the ability of Oct-4 to act as an activator or repressor [15,17-21]. In addition, the physical association of Oct-4 with PKM2 (pyruvate kinase isozyme type M2) was documented recently, suggesting that PKM2 may also play a role in regulating Oct-4 [22].
###end p 4
###begin p 5
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 801 802 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 804 805 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1074 1077 1074 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1201 1206 1201 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 1276 1279 1276 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
Proliferation of ES cells is achieved through self-renewal, and should be regulated by controlling the cell cycle. In comparison with self-renewal, little is known about the cell-cycle regulation of ES cells by Oct-4. Although Oct-4 functions as a master switch during differentiation by regulating cells that have pluripotent potential, or can develop such potential, unfortunately no Oct-4 target gene involved in ES cell-cycle regulation has been identified. As a first step towards investigating how the oct-4 gene product contributes to the cell-cycle regulation of ES cells, we analysed its potential to regulate the process of self-renewal and control the cell cycle. We found that down-regulation of oct-4 expression led to the growth arrest of ES cells by blocking cell-cycle progression in G0/G1. Deletion analysis of the functional domains of Oct-4 indicated that the overall integrity of the Oct-4 functional domains is important for the stimulation of S-phase entry. We also show in the present study that a CDKI [CDK (cyclin-dependent kinase) inhibitor] gene, p21, is a target for repression by Oct-4. Furthermore, an increase in p21 protein levels was induced by the down-regulation of oct-4 gene expression in ZHBTc4 ES cells. Therefore the down-regulation of p21 by Oct-4 may contribute to the maintenance of ES cell proliferation.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Materials and general methods
###end title 7
###begin p 8
###xml 176 178 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 431 433 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 27 31 <span type="species:ncbi:9913">calf</span>
Restriction endonucleases, calf intestinal AP (alkaline phosphatase), the Klenow fragment of DNA polymerase I and T4 DNA ligase were purchased from New England Biolabs. [alpha-32P]dCTP 3000 (Ci/mmol) was obtained from PerkinElmer. Preparation of plasmid DNA, restriction enzyme digestion, agarose gel electrophoresis of DNA, DNA ligation, bacterial transformations and SDS/PAGE of proteins were carried out using standard methods [23].
###end p 8
###begin title 9
Constructs
###end title 9
###begin p 10
###xml 334 336 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 387 393 379 385 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGATCC</underline>
###xml 471 477 463 469 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 743 749 735 741 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 1240 1246 1228 1234 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAATTC</underline>
###xml 1947 1953 1911 1917 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGATCC</underline>
###xml 3193 3195 3137 3139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
The EGFP [enhanced GFP (green fluorescent protein)]-fusion Oct-4 plasmids, pCAG-IP/FLAG-Oct-4-EGFP, pCAG-IP/FLAG-Oct-4(DeltaC)-EGFP, pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP, pCAG-IP/FLAG-Oct-4(POU)-EGFP and pCAG-IP/EGFP, were generated through the following steps. For pCAG-IP/FLAG-Oct-4-EGFP, the Oct-4 cDNA was amplified from pcDNA3/Oct-4 [17] using PCR with the primers 5'-Oct-4 (2) (5'- GATCGGATCCCGCTGGACACCTGGCTTC-3', a BamHI site is underlined) and 3'-Oct-4 (352) (5'-GATCGAATTCGGTTTGAATGCATGGGAG-3', an EcoRI site is underlined), digested with BamHI and EcoRI, and cloned into the same site of pCMV-Tag2A (Stratagene) to generate pCMV-Tag2A-Oct-4. FLAG-tagged Oct-4 was amplified from pCMV-Tag2A-Oct-4 by PCR using the primers 5'-FLAG (5'-GATCCTCGAGATGGATTACAAGGATGAC-3', a XhoI site is underlined) and 3'-Oct-4 (352), digested with XhoI and EcoRI, and cloned into the same sites of pEGFP-N1 (Takara Bio Company) to generate pEGFP-N1-FLAG-Oct-4. The plasmid pEGFP-N1-FLAG-Oct-4 was digested with XhoI and NotI and cloned into the same sites of the pCAG-IP vector. For pCAG-IP/FLAG-Oct-4(DeltaC)-EGFP, the C-terminal truncated Oct-4 fragment was amplified from pcDNA3/Oct-4 using PCR with the primers 5'-Oct-4 (2) and 3'-Oct-4 (282) (5'-GATCGAATTCGACTTGATCTTTTGCCCT-3', an EcoRI site is underlined), digested with BamHI and EcoRI, and cloned into the same site of pCMV-Tag2A to generate pCMV-Tag2A-Oct-4(DeltaC). The FLAG-tagged Oct-4(DeltaC) was then amplified from pCMV-Tag2A-Oct-4(DeltaC) using PCR with the primers 5'-FLAG and 3'-Oct-4 (282), digested with XhoI and EcoRI, and cloned into the same sites of pEGFP-N1 to generate pEGFP-N1-FLAG-Oct-4(DeltaC). The plasmid pEGFP-N1-FLAG-Oct-4(DeltaC) was digested with XhoI and NotI, and cloned into the same sites of the pCAG-IP vector. For pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP, the N-terminal truncated Oct-4 fragment was amplified from pcDNA3/Oct-4 using the PCR using primers 5'-Oct-4 (127) (5'-GATCGGATCCCGAGGAGTCCCAGGACAT-3', a BamHI site is underlined) and 3'-Oct-4 (352), digested with BamHI and EcoRI, and cloned into the same site of pCMV-Tag2A to generate pCMV-Tag2A-Oct-4(DeltaN). The FLAG-tagged Oct-4(DeltaN) was amplified from pCMV-Tag2A-Oct-4(DeltaN) using PCR with primers 5'-FLAG and 3'-Oct-4 (352), digested with XhoI and EcoRI, and cloned into the same sites of pEGFP-N1 to generate pEGFP-N1-FLAG-Oct-4(DeltaN). The plasmid pEGFP-N1-FLAG-Oct-4(DeltaN) was digested with XhoI and NotI, and cloned into the same sites of the pCAG-IP vector. For the plasmid pCAG-IP/FLAG-Oct-4(POU)-EGFP, the Oct-4 POU fragment was amplified from pcDNA3/Oct-4 by PCR using the primers 5'-Oct-4 (127) and 3'-Oct-4 (282), digested with BamHI and EcoRI, and cloned into the same site of pCMV-Tag2A to generate pCMV-Tag2A-Oct-4(POU). FLAG-tagged Oct-4(POU) was amplified from pCMV-Tag2A-Oct-4(POU) by PCR using the primers 5'-FLAG and 3'-Oct-4 (282), digested with XhoI and EcoRI, and cloned into the same sites of pEGFP-N1 to generate pEGFP-N1-FLAG-Oct-4(POU). The plasmid pEGFP-N1-FLAG-Oct-4(POU) was digested with XhoI and NotI, and cloned into the same sites of pCAG-IP vector. The description of plasmid pCAG-IP/EGFP has been described previously [24].
###end p 10
###begin p 11
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 116 122 116 122 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCGAG</underline>
###xml 205 213 205 213 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGGCCGC</underline>
To generate pcDNA3/p21, full-length p21 cDNA was amplified from IRAV-6A9 by PCR using the primer 5'-p21 (1) (5'-GATCCTCGAGATGTCCAATCCTGGTGAT-3', an XhoI site is underlined) and primer 3'-p21 (159) (5'-GATCGCGGCCGCTCAGGGTTTTCTCTTGCA-3', a NotI site is underlined), digested with XhoI and NotI, and cloned into the same sites of pCAG-IP vector to generate pCAG-IP/p21. The plasmid pCAG-IP/p21 was digested with XhoI, blunted with Klenow fragment, and redigested with NotI. The excised fragment was ligated into the EcoRV and NotI sites of pcDNA3 (Invitrogen) to generate pcDNA3/p21.
###end p 11
###begin title 12
Cell culture, cell growth curve and population-doubling time
###end title 12
###begin p 13
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 307 308 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 193 197 <span type="species:ncbi:9913">calf</span>
ZHBTc4 ES cells were grown as described previously [24,25]. HEK (human embryonic kidney)-293T cells were maintained in DMEM (Dulbecco's modified Eagle's medium) with 10% heat inactivated fetal calf serum (Gibco-BRL), 100 units/ml penicillin and 100 mug/ml streptomycin. An equal number of ZHBTc4 cells (1x105 cells) were plated in duplicate in 0.2% gelatine-coated 60-mm dishes and cultured with or without doxycycline (1 mug/ml). Cells were harvested at days 1, 2 and 3 after plating. The total number of cells was counted in each individual plate with a haemocytometer, and the mean was calculated. The population-doubling time was estimated by the linear regression between log cell number and culture time.
###end p 13
###begin title 14
Western blot analysis
###end title 14
###begin p 15
Western blot analysis was performed using anti-Oct-4 (C-10; Santa Cruz Biotechnology), anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase, V-18; Santa Cruz Biotechnology), anti-p21 (F5; Santa Cruz Biotechnology), anti-p53 (CM5; Novocastra Immunohistochemistry) or anti-actin (I-19; Santa Cruz Biotechnology) antibodies, and reactive bands were detected by chemiluminescence using the Western Lightening system (PerkinElmer Life Sciences).
###end p 15
###begin title 16
Cell-cycle analysis
###end title 16
###begin p 17
ZHBTc4 ES cells were harvested at 72 h after doxycycline treatment, washed twice in PBS, and were fixed in 70% ethanol at -20 degreesC for 20 min. After a further two washes in PBS, the fixed cells were resuspended in PBS containing 100 mug/ml RNase A and incubated at 37 degreesC for 30 min. The cells were stained with PI (propidium iodide) solution (33 mug/ml PI containing 10% Nonidet P40) for 30 min. They were then analysed by flow cytometry (FACSCalibur; BD Biosciences).
###end p 17
###begin title 18
Establishment of the ZHBTc4 ES cell line expressing Oct-4 truncation mutants
###end title 18
###begin p 19
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 388 389 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
ZHBTc4 ES cell lines stably expressing Oct-4 truncation mutants were established as described previously [26]. Briefly, to generate stably expressing ES cell lines, pCAG-IP/EGFP, pCAG-IP/FLAG-Oct-4-EGFP, pCAG-IP/FLAG-Oct-4(DeltaC)-EGFP, pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP and pCAG-IP/FLAG-Oct-4(POU)-EGFP were linearized with PvuI and 6 mug of each was transfected into ZHBTc4 ES cells (1x107) using a MicroPorator (Digital Bio Technology). At 48 h post-electroporation, puromycin (Sigma) was added to a final concentration of 1 mug/ml to select clones carrying stably integrated plasmid DNA. After selection of transfected ZHBTc4 cells, monoclonal cell lines were isolated by picking individual puromycin-resistant colonies.
###end p 19
###begin title 20
AP staining, immunocytochemistry and RT (reverse transcription)-PCR
###end title 20
###begin p 21
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
AP was stained with an AP staining kit (Sigma) as described previously [24]. For immunocytochemistry, ZHBTc4 ES cells expressing Oct-4 deletion mutants were washed in PBS, fixed for 30 min at 37 degreesC with 3.7% paraformaldehyde solution (3.7% formaldehyde and 0.18% Triton X-100), and stained with the following antibodies: anti-SSEA-1 (480; Santa Cruz Biotechnology), anti-Nanog (ab21603; Abcam) or anti-Sox-2 (Y-17; Santa Cruz Biotechnology). After washing with PBS, the plates or slides were incubated with TRITC (tetramethylrhodamine beta-isothiocyanate)-conjugated secondary antibody (Sigma). Fluorescence was detected with a fluorescence microscope (IX71; Olympus) equipped with a DP71 digital camera (Olympus).
###end p 21
###begin p 22
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
Total RNA was prepared from ZHBTc4 ES cells expressing Oct-4 deletion mutants using an RNeasy mini kit (Qiagen) with on-column DNase treatment, and mRNA was purified with an Oligodex-dT mRNA mini kit (Qiagen) followed by cDNA synthesis using a Superscript first-strand synthesis system for RT-PCR (Invitrogen), according to the manufacturer's instructions. RT-PCRs for the Oct-4 downstream target genes and differentiation marker genes were performed with gene-specific primer sets as described previously [12,24].
###end p 22
###begin title 23
Northern blot analysis
###end title 23
###begin p 24
###xml 381 384 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 426 428 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 375 380 <span type="species:ncbi:10090">mouse</span>
For Northern blotting, total cellular RNAs were prepared using TRIzol(R) reagent (Invitogen) and aliquots (10 mug/lane) were separated on 1.5% agarose/formaldehyde gels. RNA was transferred on to Hybond nylon membranes (Amersham Biosciences) and cross-linked to the membrane in a GS Gene Linker UV Chamber (Bio-Rad). The EcoRI- and NotI (0.48 kb)-digested DNA fragments from mouse p21 cDNA were gel purified and labelled with 32P using a Prime-It II Random Primer Labeling kit (Stratagene). Hybridizations were carried out overnight using the radiolabelled probe in ExpressHyb Solution (Clontech) at 68 degreesC. The blots were washed twice at 68 degreesC with 2xSSC buffer (1xSSC is 0.15 M NaCl/0.0015 M sodium citrate)/0.1% SDS and radiolabelled bands were visualized by autoradiography.
###end p 24
###begin title 25
Reporter gene assays
###end title 25
###begin p 26
###xml 340 347 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
ZHBTc4 or HEK-293T cells were transiently transfected with plasmids by electroporation using a MicroPorator (Digital Bio Technology) or VivaMagic Reagent (Vivagen) according to the manufacturer's instructions. Luciferase assays were performed with the dual-luciferase assay system, in accordance with the manufacturer's protocol (Promega). Renilla luciferase activities were used to normalize the transfection efficiency.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
Oct-4 down-regulation inhibits ES cell proliferation
###end title 28
###begin p 29
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 582 587 582 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1052 1060 1052 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
ES cells have remarkable abilities for self-renewal and can produce pluripotent daughter cells indefinitely [27]. Both processes might be important for maintaining the stemness of ES cells; however, little is known about the regulation of the cell-cycle fate in ES cells. To investigate the molecular mechanisms involved in ES cell proliferation, we studied the effect of Oct-4, a key regulator of pluripotency, on ES cell-cycle control using ZHBTc4 ES cells. These ES cells have both endogenous alleles of oct-4 inactivated by gene targeting and contain the Tet (tetracycline)-off oct-4 regulatory system [12]. The cells were colonized and grown like normal undifferentiated ES cells under the maintenance of Oct-4 transgene expression (Figure 1A, upper panels); however, upon treatment with doxycycline, a tetracycline analogue, as previously reported [12,24], definite morphological changes towards differentiation occurred as time elapsed. The cells flattened out and acquired enlarged nuclei and cytoplasm 3 days after treatment with doxycycline (Figure 1A, lower panels).
###end p 29
###begin title 30
Growth inhibition of ES cells by the down-regulation of Oct-4
###end title 30
###begin p 31
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 363 364 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 475 476 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 788 789 785 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1285 1286 1281 1282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1542 1543 1538 1539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1545 1546 1541 1542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1555 1556 1551 1552 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) Time-dependent effects of the down-regulation of Oct-4 on ES cell growth and colony morphology. ZHBTc4 ES cells (3x103) were plated on to 0.2% gelatin-coated 35-mm dishes and treated without (labelled as -Dox) or with 1 mug/ml doxycycline (labelled as +Dox) for 5 days. Cells were monitored daily using an inverted phase-contrast microscope (IX71; Olympus). (B) Effects of Oct-4 down-regulation on the proliferation of ZHBTc4 ES cells. ZHBTc4 ES cells were seeded at 1x105 cells per 0.2% gelatin-coated 60-mm dish and grown in ES cell medium supplemented with (+Dox) or without (-Dox) doxycycline. Cells were counted at 24 h intervals with a haemocytometer for a total of 72 h. Values are means+/-S.D. Three independent experiments were performed, all of which gave similar results. (C) Western blot analysis of Oct-4 down-regulation in ZHBTc4 ES cells following doxycycline treatment. ZHBTc4 ES cells were treated with 1 mug/ml doxycycline and were extracted 0, 6, 12, 24, 36 and 48 h after doxycycline treatment. The extracted proteins were resolved by SDS/PAGE (12% gels), transferred on to a PVDF membrane, and immunoblotted with anti-Oct-4 antibody (C-10; Santa Cruz Biotechnology) (upper panel). The expression level of GAPDH was used as an internal control (bottom panel). (D) Effects of Oct-4 down-regulation on cell-cycle progression. The DNA contents of ZHBTc4 ES cells cultured in the absence (-Dox) or presence (+Dox) of doxycycline for 72 h were measured by fluorescence with PI staining. M1, M2 and M3 represent gating for G0/G1, S and G2/M populations respectively. Values given are means+/-S.D. Three independent experiments gave similar results. Ab, antibody; WB, Western blot.
###end p 31
###begin p 32
###xml 609 617 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
To determine whether the down-regulation of Oct-4 gene expression could alter ES cell growth kinetics, the ZHBTc4 ES cells were cultured in the absence (-Dox) or presence (+Dox) of doxycycline. The growth property of ZHBTc4 ES cells with inhibited Oct-4 expression was markedly different from those expressing Oct-4. The doubling time of ZHBTc4 ES cells, cultured in the presence of doxycycline, was increased from 11.95 h (the doubling time of ZHBTc4 ES cells cultured in the absence of doxycycline) to 24.75 h, which indicated that down-regulation of Oct-4 in ES cells significantly altered ES cell growth (Figure 1B).
###end p 32
###begin p 33
###xml 169 177 169 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
The addition of doxycycline to ZHBTc4 ES cells resulted in the rapid repression of Oct-4 transgene expression, as determined by Western blotting of total cell extracts (Figure 1C, upper panel). Expression of the Oct-4 transgene in ZHBTc4 ES cells can be completely turned off within 24 h. Approximately equal amounts of total protein were examined for each of the cell extracts (Figure 1C, lower panel).
###end p 33
###begin p 34
###xml 371 372 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 401 409 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 468 476 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 600 601 600 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 603 604 603 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 837 838 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 840 841 840 841 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Inhibition of proliferation is typically associated with cell-cycle arrest. To investigate this possibility, ZHBTc4 ES cells were cultured in the absence (-Dox) or presence (+Dox) of doxycycline for 72 h. The DNA contents were then analysed by PI staining and flow cytometry. The down-regulation of Oct-4 expression induced a substantial accumulation of ES cells in the G0/G1-phase of the cell cycle (Figure 1D, right-hand panel), when compared with control ES cells (Figure 1D, left-hand panel). Down-regulation of Oct-4 led to a 43% increase (from 35.7% to 51.1%) in the number of ES cells in the G0/G1-phase of the cell cycle. We found that Oct-4 down-regulation reduced the S-phase population by 30% (from 43.1% to 30.1%). Thus Oct-4 down-regulation in ES cells inhibits cellular proliferation by blocking cell-cycle progression in G0/G1.
###end p 34
###begin title 35
The overall integrity of the Oct-4 functional domains is necessary to achieve its full potential for self-renewal potential
###end title 35
###begin p 36
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 351 359 343 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 714 715 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 984 992 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1097 1105 1080 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1261 1269 1244 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1318 1320 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1321 1323 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1324 1326 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1441 1449 1424 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1598 1606 1581 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 2041 2049 2016 2024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 2226 2234 2201 2209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 840 845 <span type="species:ncbi:10090">mouse</span>
Oct-4 contains N-terminal and C-terminal transactivation domains, as well as a POU DNA-binding domain [28]. To define the critical region(s) within Oct-4 that are required for ES cell self-renewal, the pCAG-IP/EGFP, pCAG-IP/FLAG-Oct-4-EGFP, pCAG-IP/FLAG-Oct-4(DeltaC)-EGFP, pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP and pCAG-IP/FLAG-Oct-4(POU)-EGFP constructs (Figure 2A) were generated by the PCR method. We constructed plasmids expressing GFP fusions of the Oct-4 truncation mutants in order to monitor the expression of Oct-4 proteins. After selection of pCAG-IP/EGFP, pCAG-IP/FLAG-Oct-4-EGFP, pCAG-IP/Flag-Oct-4(DeltaC)-EGFP, pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP or pCAG-IP/FLAG-Oct-4(POU)-EGFP-transfected ZHBTc4 cells, 3x103 stable transfectants were seeded on to 35-mm dishes containing 1 mug/ml doxycycline to repress the tetracycline-repressible mouse Oct-4 transgene. The amounts of Oct-4 or Oct-4 deletion mutant proteins in the different clones were determined by Western blot analysis (Figure 2B). Although no Oct-4 protein could be detected in ZHBTc4 ES cells stably transfected with pCAG-IP/EGFP (Figure 2B, lane 1), the Oct-4 or Oct-4 truncation mutant proteins were expressed at similar levels in all clonally derived ES cell lines used in the present study (Figure 2B, lanes 2-5). Consistent with previous reports [12,24,25], the Oct-4-transfected ZHBTc4 ES cells were able to maintain their self-renewal ability and stem-cell phenotype (Figure 2C, second panels). As a control, ZHBTc4 ES cells stably transfected with EGFP and cultured in the presence of doxycycline underwent differentiation (Figure 2C, top panels). The behaviour of the N-terminal domain and/or the C-terminal domain deletion mutants of Oct-4 were also investigated. Interestingly, the ZHBTc4 ES cells expressing FLAG-tagged Oct-4(DeltaC)-EGFP or FLAG-tagged Oct-4(DeltaN)-EGFP proteins were able to maintain their self-renewal ability and stem-cell phenotype, but the sizes of the colonies were smaller than those of the ZHBTc4 ES cells expressing full-length Oct-4 (Figure 2C, third and fourth panels). When FLAG-tagged Oct-4(POU)-EGFP was stably introduced into ZHBTc4 ES cells, it failed to maintain stem-cell renewal and underwent differentiation (Figure 2C, bottom panels).
###end p 36
###begin title 37
Different abilities of the Oct-4 deletion mutants to confer self-renewal
###end title 37
###begin p 38
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 251 252 251 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1010 1011 994 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
(A) Schematic representation of the Oct-4-EGFP fusion construct and its derivatives with deleted domains. The functional domains located within Oct-4 are indicated as NTD (N-terminal domain), POU (POU DNA-binding domain) and CTD (C-terminal domain). (B) Immunoblot analysis of the expression of Oct-4 deletion mutants in stably transfected ZHBTc4 cells. ZHBTc4 ES cells were stably transfected with pCAG-IP/EGFP (labelled as EGFP; lane 1), pCAG-IP/FLAG-Oct-4-EGFP (Flag-Oct-4-EGFP; lane 2), pCAG-IP/FLAG-Oct-4(DeltaC)-EGFP [Flag-Oct-4(DeltaC)-EGFP; lane 3], pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP [Flag-Oct-4(DeltaN)-EGFP; lane 4] or pCAG-IP/FLAG-Oct-4(POU)-EGFP [Flag-Oct-4(POU)-EGFP; lane 5], and total cell lysates were fractionated by SDS/PAGE (12% gels) and visualized by Western blotting with anti-FLAG (M2; Sigma) or anti-GAPDH (V-18; Santa Cruz Biotechnology) antibodies. The position of the prestained molecular-mass marker (New England Biolabs) is indicated to the left of the gel (molecular mass in kDa). (C) Self-renewal potentials of Oct-4 deletion mutants. ZHBTc4 ES cells stably transfected with pCAG-IP/EGFP (EGFP), pCAG-IP/FLAG-Oct-4-EGFP (Flag-Oct-4-EGFP), pCAG-IP/FLAG-Oct-4(DeltaC)-EGFP [Flag-Oct-4(DeltaC)-EGFP], pCAG-IP/FLAG-Oct-4(DeltaN)-EGFP [Flag-Oct-4(DeltaN)EGFP] or pCAG-IP/FLAG-Oct-4(POU)-EGFP [Flag-Oct-4(POU)-EGFP] were cultured in the presence of doxycycline. Phase-contrast (left-hand panels, grey colour) and fluorescence views (right-hand panels, green colour) are shown. Ab, antibody; WB, Western blot.
###end p 38
###begin title 39
The N-terminal and C-terminal domains of Oct-4 are important for stimulation of S-phase entry
###end title 39
###begin p 40
###xml 403 411 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 886 894 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
To investigate the functional region(s) of the Oct-4 protein required for the stimulation of ES cell proliferation, the inhibitory potential of ZHBTc4 ES cells expressing Oct-4 deletion mutants was analysed by cell counting. Deletion of the Oct-4 C-terminal domain [Oct-4(DeltaC)-EGFP] produced a polypeptide with approx. 40% reduced ES cell proliferation ability relative to intact Oct-4 (Oct-4-EGFP) (Figure 3A). Deletion of amino acids from the N-terminus of Oct-4 [Oct-4(DeltaN)-EGFP] further reduced the ES cell proliferation properties (by approx. 70%), whereas ZHBTc4 ES cells expressing Oct-4(POU)-EGFP failed to stimulate ES cell proliferation. Differences in ES cell proliferation potential among the various Oct-4 deletion mutants were not due to differences in protein amounts since Western blot analysis revealed equivalent amounts of protein produced from each construct (Figure 2B).
###end p 40
###begin title 41
Functional regions of Oct-4 required for stimulation of S-phase entry of ES cells
###end title 41
###begin p 42
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 410 411 410 411 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 412 413 412 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 528 529 528 529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 544 545 544 545 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 568 569 564 565 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 592 593 584 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 615 616 607 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 702 703 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 705 706 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 715 716 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) Relative growth rate of ZHBTc4 ES cells expressing Oct-4 deletion mutants. Cells (3x103) were plated on to 0.2% gelatin-coated 35-mm dishes and counted at 5 days with a haemocytometer. Relative self-renewal ability values are shown to the right, with the value obtained by Oct-4 taken as 100%. Each bar represents the average values of two experiments. Three independent experiments gave similar results. (B-F) Effects of Oct-4 deletion mutants on ES cell-cycle progression. DNA contents of ZHBTc4 ES cells expressing EGFP (B), Oct-4-EGFP (C), Oct-4(DeltaC)-EGFP (D), Oct-4(DeltaN)-EGFP (E) or Oct-4(POU)-EGFP (F) were measured by fluorescence with PI staining. M1, M2 and M3 represent gating for G0/G1, S and G2/M populations respectively. Values shown are means+/-S.D. Three independent experiments gave similar results.
###end p 42
###begin p 43
###xml 161 174 161 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3B&#8211;3F</xref>
###xml 232 240 232 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 352 361 352 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 390 398 390 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 555 556 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 558 559 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
To investigate the cell-cycle distribution, the DNA content of ZHBTc4 ES cells expressing Oct-4 deletion mutants was analysed by PI staining and flow cytometry (Figures 3B-3F). Compared with ZHBTc4 ES cells expressing intact Oct-4 (Figure 3C), deletion of the N-terminal or C-terminal domain of Oct-4 expression reduced the number of cells in S-phase (Figures 3D and 3E). As can be seen in Figure 3(F), the deletion of both the N-terminal and C-terminal domains of Oct-4 [Oct-4(POU)-EGFP] resulted in a significant increase in the number of cells in the G0/G1 fraction that was accompanied by a decrease in the number of S-phase cells, indicating the failure of ES cell-cycle progression. We also performed the same experiments using different clones and obtained similar results (J. Lee and J. Kim, unpublished work). These results indicated that the overall integrity of Oct-4 is necessary for the full proliferation potential of ES cells.
###end p 43
###begin title 44
Different abilities of Oct-4 deletion mutants to maintain the undifferentiated state
###end title 44
###begin p 45
###xml 149 157 149 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 598 606 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
The small colony size and reduced proliferation abilities of doxycycline-treated ZHBTc4 ES cells expressing Oct-4 N- or C-terminal deletion mutants (Figure 2C) suggested change or collapse to maintain the undifferentiated state of the ES cells. To verify this hypothesis, we examined known molecular markers of undifferentiated ES cells. To stain for AP activity (a marker for pluripotent cells of embryonic origin) [29], colonies were tested for staining the cells for AP. ZHBTc4 ES cells expressing FLAG-tagged Oct-4(DeltaC)-EGFP or FLAG-tagged Oct-4(DeltaN)-EGFP proteins contained AP activity (Figure 4A, panels e-h) comparable with that in ZHBTc4 ES cells expressing full-length Oct-4 (panels c and d). However, the clones expressing FLAG-Oct-4(POU)-EGFP (panels i and j) or EGFP alone (panels a and b) had lost this characteristic, which pointed to a failure to maintain the undifferentiated state.
###end p 45
###begin title 46
Characterization of ZHBTc4 ES cells expressing Oct-4 deletion mutants
###end title 46
###begin p 47
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 184 192 184 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 462 470 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 476 477 476 477 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 719 727 719 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 733 734 733 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 989 997 989 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1003 1004 1003 1004 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1099 1104 1099 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-4</italic>
###xml 1106 1111 1106 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rex-1</italic>
###xml 1113 1118 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx-2</italic>
###xml 1123 1129 1123 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand-1</italic>
###xml 1205 1209 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hprt</italic>
(A) Expression of AP. AP activity was assessed in ZHBTc4 ES cells expressing Oct-4 deletion mutants. The expression vectors used in this experiment were the same as those described in Figure 2(A). (B) Expression of SSEA-1. The expression of SSEA-1 in ZHBTc4 ES cells expressing Oct-4 deletion mutants was analysed with an anti-SSEA-1 antibody (480; Santa Cruz Biotechnology). The expression vectors used in this experiment were the same as those described in in Figure 2(A). (C) Expression of Nanog. The expression of Nanog in ZHBTc4 ES cells expressing Oct-4 deletion mutants was analysed with an anti-Nanog antibody (ab21603; Abcam). The expression vectors used in this experiment were the same as those described in Figure 2(A). (D) Expression of Sox2. The expression of Sox2 in ZHBTc4 ES cells expressing Oct-4 deletion mutants was analysed with an anti-Sox2 antibody (Y-17; Santa Cruz Biotechnology). The expression vectors used in this experiment were the same as those described in Figure 2(A). (E) Expression of Oct-4 downstream target genes and lineage-specific markers. RT-PCR analyses of Fgf-4, Rex-1, Cdx-2 and Hand-1 mRNAs were performed in ZHBTc4 ES cells expressing Oct-4 deletion mutants. Hprt was used as a control to qualify the RT-PCR results. Following amplification, an aliquot of each product was analysed by staining the gel with ethidium bromide. The ES cell lines from which the input RNAs used in the RT reactions were derived are shown above the panel. Three independent experiments gave similar results.
###end p 47
###begin p 48
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 336 344 328 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 367 375 359 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 399 407 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 498 511 490 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4B&#8211;4D</xref>
###xml 579 592 571 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4B&#8211;4D</xref>
###xml 621 634 613 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4B&#8211;4D</xref>
We also examined other known molecular markers of undifferentiated ES cells, such as SSEA-1 [30], Nanog [31,32] and Sox2 [33]. Consistent with the results from staining for AP activity, ZHBTc4 ES cells expressing FLAG-tagged Oct-4(DeltaC)-EGFP or FLAG-tagged Oct-4(DeltaN)-EGFP proteins were positive for immunostaining against SSEA-1 (Figure 4B, panels g-l), Nanog (Figure 4C, panels g-l) or Sox2 (Figure 4D, panels g-l), comparable with that seen in ZHBTc4 ES cells expressing full-length Oct-4 (Figures 4B-4D, panels d-f). However, the clones expressing FLAG-Oct-4(POU)-EGFP (Figures 4B-4D, panels m-o) or EGFP alone (Figures 4B-4D, panels a-c) had lost these characteristics.
###end p 48
###begin p 49
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-4</italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rex-1</italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 218 226 218 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
To investigate further the features of the ZHBTc4 ES cells expressing these mutants, we investigated the expression level of known Oct-4 downstream target genes such as Fgf-4 [34] and Rex-1 [35] by RT-PCR. As shown in Figure 4(E), the expression of the two Oct-4 downstream target genes was detected in tetracycline-treated ZHBTc4 ES cells stably transfected with FLAG-Oct-4-EGFP (lane 2), FLAG-Oct-4(DeltaC)-EGFP (lane 3) or FLAG-Oct-4(DeltaN)-EGFP (lane 4) cDNAs.
###end p 49
###begin p 50
###xml 77 85 77 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx-2</italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx-2</italic>
###xml 504 509 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx-2</italic>
###xml 592 598 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand-1</italic>
###xml 646 648 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
We also evaluated the expression of differentiated cell markers. As shown in Figure 4(E), the expression of Cdx-2 mRNA, which is implicated in trophoblast differentiation [36], was detected in ZHBTc4 ES cells expressing vector (lane 1) or FLAG-Oct-4(POU)-EGFP (lane 5). Unexpectedly, the expression of Cdx-2 mRNA was also detected in ZHBTc4 ES cells expressing FLAG-Oct-4(DeltaC)-EGFP (lane 3) and FLAG-Oct-4(DeltaN)-EGFP (lane 4), which were also positive for the undifferentiated markers. However, the Cdx-2 gene was not detectable in ZHBTc4 ES cells expressing FLAG-tagged Oct-4 (lane 2). Hand-1 mRNA, a marker of trophoblast differentiation [37], also appeared in ZHBTc4 ES cells expressing FLAG-Oct-4(DeltaC)-EGFP (lane 3) and FLAG-Oct-4(DeltaN)-EGFP (lane 4), indicating the induction of differentiation programmes. Taken together, these properties all suggested that ES cells, expressing full-length Oct-4, expanded normally and remained in an undifferentiated state, whereas Oct-4(POU)-expressing ES cells did not. Interestingly, the status of the Oct-4(DeltaC)- or Oct-4(DeltaN)-expressing ES cells seems to be intermediate between the undifferentiated and differentiated states.
###end p 50
###begin title 51
Oct-4 down-regulation induces expression of p21 in ZHBTc4 ES cells
###end title 51
###begin p 52
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 241 242 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 595 603 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 687 690 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 845 848 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 906 911 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">oct-4</italic>
###xml 924 932 924 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1124 1132 1124 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1300 1308 1300 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1455 1457 1455 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1730 1738 1730 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
It has been well-characterized that the G1-S transition is mainly regulated by G1 regulatory molecules [38]. Among these regulatory molecules, p21 is a member of the universal CDKIs and plays several critical roles in the regulation of the G1-S transition [39]. To investigate whether Oct-4 down-regulation results in elevated p21 levels in ES cells, we examined p21 levels in ZHBTc4 ES cells. In this system, the addition of doxycycline to the growth medium of ZHBTc4 ES cells resulted in the rapid repression of Oct-4 expression, as determined by Western blot analysis of total cell extracts (Figure 1C). To examine the effects of the down-regulation of Oct-4 expression on endogenous p21 gene expression, Northern blot analysis was performed with total RNA, isolated from these cells in the presence of doxycycline. The results revealed that p21 transcript levels were increased upon down-regulation of oct-4 expression (Figure 5A). We also investigated the induction of p21 protein when Oct-4 expression was down-regulated. Western blot analysis showed almost no signal for p21 protein when Oct-4 is expressed normally (Figure 5B, lane 1). However, down-regulation of Oct-4 induced p21 protein expression, and a strong induction of p21 was observed at 48 h after the addition of the doxycycline (Figure 5B). It has been well demonstrated that p21 expression is regulated at the transcriptional level by both p53-dependent and -independent mechanisms [40]; therefore we decided to investigate the levels of p53 protein in ZHBTc4 ES cells. The analysis of ES cell extracts by immunoblotting, carried out at various time intervals, demonstrated that the level of p53 protein was slightly down-regulated by Oct-4 down-regulation (Figure 5B, middle panel).
###end p 52
###begin title 53
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
Up-regulation of p21 gene expression in ZHBTc4 ES cells down-regulating Oct-4
###end title 53
###begin p 54
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 669 670 669 670 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1275 1276 1275 1276 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1647 1648 1647 1648 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1953 1960 1953 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2168 2169 2166 2167 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2205 2208 2203 2206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 1403 1408 <span type="species:ncbi:10090">mouse</span>
###xml 1465 1470 <span type="species:ncbi:10090">mouse</span>
###xml 1613 1618 <span type="species:ncbi:10090">mouse</span>
(A) Northern blot analysis of p21 mRNA expression. ZHBTc4 ES cells were harvested for the preparation of total RNA at 0, 12, 24, 36 and 48 h following doxycycline treatment. Total RNA was fractionated on a 6% formaldehyde/1.5% agarose gel, transferred on to a nylon membrane, and probed with mouse p21 cDNA as described in the Materials and methods section (upper panel). The ethidium bromide staining of the agarose gel used for the Northern blotting is shown to demonstrate that equal amounts of total RNA were loaded into each lane (lower panel). Arrows indicate the position of migration of the respective RNAs. Three independent experiments gave similar results. (B) Western blot analysis of p21 expression. Total cell extracts were prepared from ZHBTc4 ES cells at 0, 12, 24, 36 and 48 h following doxycycline treatment. The extracts were resolved by SDS/PAGE (15% gel), transferred on to a PVDF membrane, and immunoblotted with anti-p21 (F5; Santa Cruz Biotechnology), anti-p53 (CM5; Novocastra Immunohistochemistry) or anti-actin (I-19; Santa Cruz Biotechnology) antibodies. The positions of the prestained molecular-mass markers (New England Biolabs) are indicated to the left of the gel (molecular mass in kDa). Three independent experiments gave similar results. (C) Schematic representation of the reporter plasmid and Oct-4 expression vector. The p21 luciferase reporter plasmid contains a mouse genomic DNA sequence from nucleotides -3309 to +12. The mouse p21 promoter is indicated by an open box and the luciferase gene is indicated by a solid box. The expression vector driving the production of mouse Oct-4 is also represented. (D) Transcriptional activation of the p21 promoter by down-regulation of Oct-4 in ZHBTc4 ES cells. ZHBTc4 ES cells were transfected with the p21 luciferase reporter plasmid and cultured in the absence (-Dox, lane 1) or presence (+Dox, lane 2) of doxycycline. Firefly luciferase activity was normalized with Renilla luciferase activity to correct for transfection efficiencies. Each transfection was performed at least three times independently, and values are means+/-S.D. Fold-induction is relative to the empty vector. (E) Transcriptional repression of the p21 promoter by Oct-4. Co-transfections of HEK-293T cells were performed with 0.25 mug of reporter plasmid and 0, 0.25, 0.5 or 1.0 mug of pcDNA3/Oct-4 expression plasmid. Individual transfected DNAs were adjusted to contain equal amounts of total DNA by the addition of the empty expression vector pcDNA3. The average relative transactivation and standard error is presented, with the relative transactivation values obtained with pcDNA3/Oct-4 taken as 100%. The values shown are taken from three independent experiments.
###end p 54
###begin p 55
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 775 778 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 840 843 840 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1172 1180 1172 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1233 1236 1233 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 190 193 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To demonstrate whether the p21 promoter could mediate a transcriptional response to Oct-4, the p21 promoter region was cloned upstream of the firefly luciferase reporter gene (Figure 5C). A CMV (cytomegalovirus)-based expression vector driving the production of Oct-4 was also generated. ZHBTc4 ES cells were transfected with the p21-luciferase reporter plasmid and cultured for 48 h in the absence (Figure 5D, lane 1) or presence (lane 2) of doxycycline. The introduction of p21-luciferase into ZHBTc4 ES cells, cultured in the absence of doxycycline, activated reporter gene transcription 118-fold. However, in the absence of Oct-4 (+Dox), reporter gene activity was increased up to 301-fold, indicating that the down-regulation of Oct-4 in ES cells causes an increases in p21 gene expression. To investigate Oct-4-mediated inhibition of p21 gene expression further, reporter and expression vectors were then introduced into HEK-293T cells and assayed for the induction of luciferase activity. The introduction of increasing amounts of pcDNA3/Oct-4 to a transfection containing fixed amounts of p21-luciferase reporter plasmid led to a reduction in luciferase activity (Figure 5E). These results suggested that Oct-4 might repress p21 promoter activity.
###end p 55
###begin title 56
DISCUSSION
###end title 56
###begin p 57
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 963 966 963 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1081 1084 1081 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
The mechanisms by which the ES cell cycle is controlled and sustained remain obscure. It is well known that Oct-4 is an essential transcriptional regulator of genes involved in maintaining the undifferentiated pluripotent state of ES cells, but little has been established as to whether the ES cell-cycle fate is regulated by this protein. In the present study, we have characterized the effect of Oct-4 on ES cell-cycle control using ZHBTc4 ES cells. Previous studies have shown that the length of G1-phase in ES cells is much shorter than in somatic cells [41-43], and in the present study we found that Oct-4 down-regulation in ES cells inhibits cellular proliferation by blocking cell-cycle progression in G0/G1. Deletion analysis of the functional domains of Oct-4 indicated that both the N-terminal and C-terminal transactivation domains of Oct-4 are important for the stimulation of S-phase entry. In addition, we also showed in the present study that the p21 gene is a target for repression by Oct-4 in ZHBTc4 ES cells. Our findings demonstrate that the down-regulation of p21 by Oct-4 may contribute to the maintenance of ES cell proliferation.
###end p 57
###begin p 58
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 763 771 755 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1251 1259 1243 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1385 1393 1377 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1398 1405 1390 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Oct-4 is a central mediator of the undifferentiated pluripotent state of ES cells. It was previously reported that maintaining Oct-4 activity within a certain range appears to be critical for stem cell self-renewal, with any increase or decrease triggering differentiation to endoderm/mesoderm or trophectoderm respectively [12]. Although Oct-4 possesses two separate transactivation domains, Oct-4 deletion mutants lacking either the N-terminal domain or the C-terminal domain are able to maintain the stem cell phenotype [25]. Consistent with this result, ZHBTc4 ES cells expressing FLAG-tagged Oct-4(DeltaC)-EGFP or FLAG-tagged Oct-4(DeltaN)-EGFP proteins were positive for undifferentiated stem cell markers, such as AP, SSEA-1, Nanog, Sox2, Fgf-4 and Rex-1 (Figure 4). However, these ES cells showed smaller colony sizes and were also positive for the expression of markers of differentiated cells, indicating that neither the N-terminal nor the C-terminal domain deletion mutant of the Oct-4 protein is sufficient to maintain the stem cell phenotype. ES cells expressing Oct-4 deletion mutants lacking either the N-terminus or the C-terminus were positive both for the undifferentiated stem cell markers and for markers of differentiated cells (Figure 4). It would be interesting, therefore, to see whether such ES cells are capable of long-term self-renewal and are pluripotent in vitro and in vivo.
###end p 58
###begin p 59
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 214 222 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 480 483 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 507 510 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 664 672 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 701 704 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 864 867 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 881 889 881 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 942 945 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 965 973 965 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1050 1053 1050 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1150 1158 1150 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1203 1206 1203 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1235 1238 1235 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1374 1376 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
Cell-cycle progression is controlled by the CDKs, and p21 is a CDKI that inhibits G1 CDK-cyclin complexes [44-46]. In the present study, the down-regulation of Oct-4 in ES cells induced p21 to a remarkable degree (Figure 5), in a time-dependent manner, both at the mRNA and protein levels. It is well known that p21 expression is regulated largely at the transcriptional level by a p53-dependent mechanism at the transcriptional level [46], which suggests that Oct-4 may regulate p21 expression through the p53 tumour suppressor gene. However, although ZHBTc4 ES cells did express p53, the down-regulation of Oct-4 did not significantly change p53 protein levels (Figure 5B). Having demonstrated that p21 expression is down-regulated by Oct-4 in ES cells, we attempted to determine whether this resulted from a direct effect of Oct-4 with regulatory element(s) in p21. As shown in Figure 5, the down-regulation of Oct-4 in ES cells increased p21 promoter activity (Figure 5D) and the introduction of increasing amounts of Oct-4 led to a reduction in p21 promoter activity (up to 40% of promoter activity) in differentiated cells (HEK-293T cell line; Figure 5E), suggesting that Oct-4 directly represses p21 promoter activity. However, p21 expression can also be regulated post-translationally by both ubiquitin-dependent and -independent proteasome-mediated degradation [47-49]. Thus it would be interesting to determine whether Oct-4 is able to control p21 stability in ES cells and induce pluripotent stem (iPS) cells.
###end p 59
###begin p 60
###xml 192 200 192 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 338 346 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 546 554 546 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
The expression of Oct-4 in doxycyclin-treated ZHBTc4 ES cells led to a consistent increase in the number of cells in S-phase, an effect that was not observed following the expression of EGFP (Figure 3). Consistent with these results, the down-regulation of Oct-4 in ES cells also led to an increase in the number of cells in G0/G1-phase (Figure 1D). To clarify the contribution of the different functional domains of the Oct-4 protein to ES cell-cycle progression, we generated ES cell lines carrying functional domain deletion mutants of Oct-4 (Figure 2A). Deletion of the N-terminal or C-terminal domain of Oct-4 reduced the number of cells in S-phase (Figure 3), indicating that the overall integrity of Oct-4 is required for its ability to stimulate cell-cycle progression in ES cells.
###end p 60
###begin p 61
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
In conclusion, it is likely that Oct-4 contributes towards maintaining cells in an undifferentiated, pluripotent or totipotent state in two ways: (i) by activating certain key genes and (ii) by silencing others. The findings of the present study provide additional evidence that Oct-4 plays a key role in regulating the ES cell cycle positively, as well as maintaining ES cell pluripotency. Therefore Oct-4-mediated p21 gene down-regulation may be a key mechanism for the stimulation of cell-cycle progression of the ICM.
###end p 61
###begin title 62
AUTHOR CONTRIBUTIONS
###end title 62
###begin p 63
Jungwoon Lee and Jungho Kim designed and performed the research, and wrote and edited the manuscript. Yeorim Go and Inyoung Kang performed some parts of the experiments and Yong-Mahn Han analysed the data. All authors discussed the results and commented on the paper.
###end p 63
###begin title 64
ACKNOWLEDGEMENTS
###end title 64
###begin p 65
We thank Dr Hitoshi Niwa (RIKEN Center for Developmental Biology, Kobe, Japan) for providing ZHBTc4 ES cells and the pCAG-IP vector.
###end p 65
###begin title 66
FUNDING
###end title 66
###begin p 67
###xml 31 182 31 182 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs1">Stem Cell Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science, and Technology, Republic of Korea</funding-source>
###xml 197 204 197 204 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="gs1">SC-2211</award-id>
###xml 211 282 211 282 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs2">BioGreen21 Program, Rural Development Administration, Republic of Korea</funding-source>
###xml 297 311 297 311 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="gs2">20070501034009</award-id>
###xml 318 462 318 462 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs3">Priority Research Centers Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology</funding-source>
###xml 477 489 477 489 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="gs3">2009-0093822</award-id>
###xml 570 671 570 671 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs4">Ministry of Education and Human Resources Development, and J. K. was a recipient of the SRG programme</funding-source>
###xml 686 697 686 697 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="gs4">200811026.1</award-id>
###xml 596 601 <span type="species:ncbi:9606">Human</span>
This work was supported by the Stem Cell Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science, and Technology, Republic of Korea [grant number SC-2211]; the BioGreen21 Program, Rural Development Administration, Republic of Korea [grant number 20070501034009]; the Priority Research Centers Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology [grant number 2009-0093822]. J. L., Y. G. and I. K. were recipients of a research fellowship BK21 from the Ministry of Education and Human Resources Development, and J. K. was a recipient of the SRG programme [grant number 200811026.1] of Sogang University.
###end p 67
###begin article-title 68
Molecular mechanism to maintain stem cell renewal of ES cells
###end article-title 68
###begin article-title 69
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells
###end article-title 69
###begin article-title 70
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Oct-4: a germline-specific transcription factor mapping to the mouse t-complex
###end article-title 70
###begin article-title 71
A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo
###end article-title 71
###begin article-title 72
###xml 37 42 <span type="species:ncbi:9606">human</span>
Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis
###end article-title 72
###begin article-title 73
###xml 57 62 <span type="species:ncbi:9606">human</span>
Oct-4 expression in inner cell mass and trophectoderm of human blastocysts
###end article-title 73
###begin article-title 74
Signalling, cell cycle and pluripotency in embryonic stem cells
###end article-title 74
###begin article-title 75
New type of POU domain in germ line-specific protein Oct-4
###end article-title 75
###begin article-title 76
Structure, expression and chromosomal location of the Oct-4 gene
###end article-title 76
###begin article-title 77
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4
###end article-title 77
###begin article-title 78
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation
###end article-title 78
###begin article-title 79
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
###end article-title 79
###begin article-title 80
###xml 48 53 <span type="species:ncbi:9606">human</span>
Expression of transcription regulating genes in human preimplantation embryos
###end article-title 80
###begin article-title 81
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Octamer binding proteins confer transcriptional activity in early mouse embryogenesis
###end article-title 81
###begin article-title 82
###xml 30 36 <span type="species:ncbi:10090">murine</span>
Octamania: the POU factors in murine development
###end article-title 82
###begin article-title 83
The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain
###end article-title 83
###begin article-title 84
Stimulation of Oct-4 activity by Ewing's sarcoma protein
###end article-title 84
###begin article-title 85
Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells
###end article-title 85
###begin article-title 86
Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins
###end article-title 86
###begin article-title 87
Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity
###end article-title 87
###begin article-title 88
A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells
###end article-title 88
###begin article-title 89
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription
###end article-title 89
###begin article-title 90
Molecular Cloning: a Laboratory Manual
###end article-title 90
###begin article-title 91
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human OCT-4 isoforms differ in their ability to confer self-renewal
###end article-title 91
###begin article-title 92
Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells
###end article-title 92
###begin article-title 93
The EWS-Oct-4 fusion gene encodes a transforming gene
###end article-title 93
###begin article-title 94
###xml 34 39 <span type="species:ncbi:9606">human</span>
Multilineage differentiation from human embryonic stem cell lines
###end article-title 94
###begin article-title 95
###xml 7 17 <span type="species:ncbi:111938">gatekeeper</span>
Oct-4: gatekeeper in the beginnings of mammalian development
###end article-title 95
###begin article-title 96
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Establishment in culture of pluripotential cells from mouse embryos
###end article-title 96
###begin article-title 97
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Embryonic stem cells: similarities and differences between human and murine embryonic stem cells
###end article-title 97
###begin article-title 98
Transcriptional regulation of nanog by OCT4 and SOX2
###end article-title 98
###begin article-title 99
Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression
###end article-title 99
###begin article-title 100
Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex
###end article-title 100
###begin article-title 101
Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites
###end article-title 101
###begin article-title 102
Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site
###end article-title 102
###begin article-title 103
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extra-embryonic membranes
###end article-title 103
###begin article-title 104
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development
###end article-title 104
###begin article-title 105
The Pezcoller lecture: cancer cell cycles revisited
###end article-title 105
###begin article-title 106
CDK inhibitors: positive and negative regulators of G1-phase progression
###end article-title 106
###begin article-title 107
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis
###end article-title 107
###begin article-title 108
G1 to S phase cell cycle transition in somatic and embryonic stem cells
###end article-title 108
###begin article-title 109
###xml 16 21 <span type="species:ncbi:9606">human</span>
Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase
###end article-title 109
###begin article-title 110
Cell cycle features of primate embryonic stem cells
###end article-title 110
###begin article-title 111
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
###end article-title 111
###begin article-title 112
p21 is a universal inhibitor of cyclin kinases
###end article-title 112
###begin article-title 113
Transcriptional regulation of the p21(WAF1/CIP1) gene
###end article-title 113
###begin article-title 114
Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation
###end article-title 114
###begin article-title 115
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination
###end article-title 115
###begin article-title 116
A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome
###end article-title 116

